Preparation method of biological polyphenol macroporous resin, macroporous resin and application of macroporous resin
By using bioporous phenol monomers to prepare macroporous resins, the toxicity and compatibility problems in the preparation of existing blood perfusion materials are solved, environmentally friendly adsorbent materials are provided, and efficient blood purification effect is achieved.
Patent Information
- Application Number
- CN202411224590.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-11-22
AI Technical Summary
The use of monomers such as styrene and divinylbenzene during the preparation of existing blood perfusion adsorbent materials is toxic, harmful to the human body and the environment, and has poor compatibility with the blood, resulting in adverse effects on practitioners and the environment.
The macroporous resin is prepared by biopolyphenol monomers such as Magnolia, resveratrol and eugenol. It is prepared by emulsion polymerization and a one-time heating process is adopted to reduce energy consumption and environmental harm during the production process, providing Environmentally friendly adsorbent material.
The prepared biopolyphenol macroporous resin has good hydrophilicity and blood compatibility, and can effectively adsorb substances of 10KD to 60KD, reducing the harm of the production process to the human body and the environment. It has a simple process and low energy consumption. It is suitable. in blood purification technology.
Smart Images

Figure SMS_9
Abstract
Description
Technical Field
[0001] The present application relates to the field of blood purification, and in particular to a preparation method of a biopolyphenol macroporous resin, a macroporous resin and applications thereof. Background Art
[0002] Blood purification is a technology that uses hemodialysis, hemofiltration, hemoperfusion and plasma exchange to remove toxins or excess components accumulated in the blood. Blood purification therapy can remove pathogens or toxins from the patient's blood and regulate the stability of the microenvironment in the body, thereby achieving the effect of alleviating and treating diseases.
[0003] In the field of blood purification, the typical application should be hemoperfusion. Hemoperfusion achieves blood purification by adsorbing macromolecular substances in the blood. It is often used for acute poisoning, uremia, severe hepatitis and other diseases, and plays a key role in clinical medicine. The core of hemoperfusion technology lies in the adsorption material. The adsorption material currently used in hemoperfusion technology is mainly polystyrene-based adsorption resin, which is usually prepared from monomers such as styrene and divinylbenzene. Since styrene and divinylbenzene are toxic to the human body, they will cause certain harm to the human body and the environment during their production and processing, and have been listed as Class 2B carcinogens; at the same time, polystyrene-based adsorption resins have poor compatibility with blood. If they are to be used clinically, the compatibility of the resin needs to be modified by various methods, and the modification process will also have adverse effects on the environment. Due to the existence of these problems, the preparation process of existing hemoperfusion materials has adverse effects on practitioners and the environment. Summary of the invention
[0004] In view of this, the purpose of the present application is to provide a method for preparing a biopolyphenol macroporous resin, a macroporous resin and its application, so as to provide an environmentally friendly method for preparing an adsorption material, thereby solving the problem that the existing method for preparing blood perfusion adsorption materials is prone to harm to the human body and the environment.
[0005] In order to achieve the above technical objectives, the first aspect of the present application provides a method for preparing a biopolyphenol macroporous resin, comprising the following steps:
[0006] Step S1, preparing oil phase and water phase respectively, wherein:
[0007] Prepare the oil phase: mix the biopolyphenol monomer, porogen and initiator, and stir evenly to obtain the oil phase;
[0008] Preparing an aqueous phase: placing a dispersant and water in a heating device, heating to a first temperature, and stirring to completely dissolve the dispersant in the water to obtain an aqueous phase;
[0009] Step S2, continuously stirring the water phase, introducing nitrogen into the heating device for protection, and dropping the oil phase into the water phase to complete the dropping to obtain a mixture;
[0010] Step S3, heating the mixture to a second temperature, stirring and keeping warm for a first period of time, to obtain a solid-liquid mixture;
[0011] Step S4, separating the solid product from the solid-liquid mixture, washing the solid product, and obtaining a biopolyphenol-based macroporous resin.
[0012] Furthermore, the biopolyphenol monomers include one or more of magnolol, resveratrol, and eugenol.
[0013] Furthermore, the biopolyphenol monomers include magnolol and resveratrol, and the mass ratio of magnolol to resveratrol is 1:(1-6)).
[0014] Furthermore, the mass ratio of biopolyphenol monomer, porogen and initiator is 1:(0.5-1.2):(0.003-0.01); the mass ratio of dispersant and water is 1:(0.005-0.015); and the volume ratio of oil phase and water phase is 1:(1-3).
[0015] Furthermore, the second temperature is 80-95° C., and the first insulation time is 4-10 hours.
[0016] Furthermore, the porogen includes one or more of toluene and isobutanol.
[0017] Furthermore, the dispersant includes one or more of gelatin, polyvinyl alcohol, and hydroxyethyl cellulose.
[0018] Furthermore, the dispersant includes gelatin and polyvinyl alcohol, and the mass ratio of gelatin to polyvinyl alcohol is 1:(1-10).
[0019] Furthermore, the initiator includes one or more of benzoyl peroxide and azobisisobutyronitrile.
[0020] Furthermore, in step S3, the time for adding the oil phase dropwise into the water phase does not exceed 10 minutes.
[0021] The second aspect of the present application provides a biopolyphenol macroporous resin prepared by the above method, wherein the average pore size of the biopolyphenol macroporous resin is 10 to 15 nm.
[0022] The third aspect of the present application provides an application of a biopolyphenol macroporous resin, which is applied to blood purification technology and adsorbs substances with a molecular weight of 10KD to 60KD.
[0023] In summary, the embodiments provided in the present application provide, on the one hand, a method for preparing a biopolyphenol macroporous resin, which mainly includes the following steps: step S1, preparing an oil phase and an aqueous phase respectively: mixing a biopolyphenol monomer, a porogen and an initiator, stirring evenly to obtain an oil phase; placing a dispersant and water in a heating device, heating to a first temperature, and stirring to completely dissolve the dispersant in the water to obtain an aqueous phase; step S2, continuously stirring the aqueous phase, and passing nitrogen protection into the heating device, dripping the oil phase into the aqueous phase, completing the dripping, and obtaining a mixture; step S3, heating the mixture to a second temperature, stirring and keeping warm for a first period of time, to obtain a solid-liquid mixture; step S4, separating the solid product in the solid-liquid mixture, washing the solid product, and obtaining a biopolyphenol-based macroporous resin. Compared with the prior art, the macroporous resin preparation method provided by the present invention uses biopolyphenol as a monomer in the production process, and does not use other monomers with strong toxicity as raw materials. At the same time, the preparation method is in the form of emulsion polymerization, and no other toxic adjuvants need to be added during the preparation process; in addition, the preparation method provided by the present application only uses one heating method during the monomer reaction process to achieve the preparation of the macroporous resin, and there is no need to perform continuous heating and heat preservation operations. Therefore, the preparation method of the macroporous resin provided by the present application is environmentally friendly and can reduce the harm caused to the human body and the environment by the production process of the macroporous resin. At the same time, the preparation method provided by the present invention has fewer heating and heat preservation times, simple procedures, and can effectively reduce the energy consumption required for the production process.
[0024] On the other hand, the present application also provides a biopolyphenol macroporous resin prepared by the above method, which has an average pore size of 10 to 15 nm, and its hydrophilicity and blood compatibility are similar to those of existing perfusion products. It can be applied to the field of blood purification without subsequent hydrophilic modification, and is used to adsorb substances with a molecular weight of 10KD to 60KD. DETAILED DESCRIPTION
[0025] The technical solutions of the embodiments of the present application are described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the specification of the present application, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection requested by the present application.
[0026] The sources of all raw materials in the present invention are not particularly limited and can be purchased from the market or prepared according to conventional methods known to those skilled in the art.
[0027] The present invention provides a method for preparing a biopolyphenol macroporous resin, and the specific steps are as follows:
[0028] Step S1, preparing oil phase and water phase respectively, wherein:
[0029] Prepare the oil phase: mix the biopolyphenol monomer, porogen and initiator, and stir evenly to obtain the oil phase;
[0030] Preparing an aqueous phase: placing a dispersant and water in a heating device, heating to a first temperature, and stirring to completely dissolve the dispersant in the water to obtain an aqueous phase;
[0031] Step S2, continuously stirring the water phase, introducing nitrogen into the heating device for protection, and dropping the oil phase into the water phase to complete the dropping to obtain a mixture;
[0032] Step S3, heating the mixture to a second temperature, stirring and keeping warm for a first period of time, to obtain a solid-liquid mixture;
[0033] Step S4, separating the solid product from the solid-liquid mixture, washing the solid product, and obtaining a biopolyphenol-based macroporous resin.
[0034] Specifically, firstly, biopolyphenol monomers, porogens and initiators are mixed to form an oil phase; then, a dispersant is mixed with water, and the melting point of the dispersant is used as the first heating temperature, and stirring is started at the same time to dissolve the dispersant to form an aqueous phase; the oil phase is dripped into the aqueous phase at a certain rate, and under stirring conditions, the oil phase is rapidly distributed in the aqueous phase to form droplets wrapped by the aqueous phase; at the same time, under heating conditions, free radicals generated by the biopolyphenol monomers and the initiator are rapidly polymerized in the droplets to form resin microspheres, and finally, the organic solvent on the surface of the macroporous resin and inside the pores is cleaned to obtain the macroporous resin.
[0035] In some embodiments, the biopolyphenol monomers include one or more of magnolol, resveratrol, and eugenol.
[0036] Specifically, magnolol, resveratrol, and eugenol are extracted from natural plants, have low toxicity, are not likely to cause harm to the human body and the environment during use, and have environmentally friendly characteristics. In addition, magnolol, resveratrol, and eugenol belong to biological polyphenol monomers, and the double bonds they contain can cause biological polyphenol monomers to undergo polymerization under certain conditions, and the hydroxyl groups they provide can combine with water to further improve the hydrophilicity of the macroporous resin.
[0037] All of them have a benzene ring structure, which can enhance the stability and reactivity of the molecule. In addition, magnolol also contains phenolic hydroxyl groups, which have unshared electron pairs and are very easy to lose electrons, prompting magnolol to participate in polymerization reactions. In addition, the hydrogen bonds on the phenolic hydroxyl groups can also interact with other molecules or ions to participate in polymerization reactions. Resveratrol also contains multiple hydroxyl groups, which can provide more reaction sites for polymerization reactions and promote its reaction with other substances. Eugenol has an allyl structure, and the double bonds in the allyl structure are unsaturated, which is easy to participate in addition reactions and promote the occurrence of polymerization reactions.
[0038] In some embodiments, the biopolyphenol monomers include magnolol and resveratrol, and the mass ratio of magnolol to resveratrol is 1:(1-6).
[0039] Specifically, in some embodiments, the biopolyphenol monomers include the above-mentioned magnolia officinalis and resveratrol. Since magnolia officinalis and resveratrol contain a large number of hydroxyl groups, the macroporous resin prepared from the two has good hydrophilicity, a low hemolysis rate, and is safer in actual application.
[0040] In some embodiments, the mass ratio of the biopolyphenol monomer, the porogen, and the initiator is 1:(0.5-1.2):(0.003-0.01);
[0041] In some embodiments, the mass ratio of dispersant to water is 1:(0.005-0.015);
[0042] In some embodiments, the volume ratio of the oil phase to the water phase is 1:(1-3).
[0043] Specifically, in some embodiments, reasonable control of the ratio of each component in the preparation process of the macroporous resin is helpful to prepare a macroporous resin with uniform pore size, large specific surface area, good hydrophilicity, low hemolysis rate and large adsorption capacity.
[0044] In some embodiments, the second temperature is 80-95° C., and the first insulation time is 4-10 hours.
[0045] Specifically, in some embodiments, the second heating temperature is set to 80-95°C, which can not only meet the activation requirements of the reaction, but also accelerate the reaction rate between monomers, shorten the reaction time, and thus improve production efficiency; the first insulation time is controlled at 4-10 hours, which can ensure that the reactants have sufficient time to interact with each other to achieve the expected degree of reaction; at the same time, under the premise of ensuring product quality, unnecessary time consumption is reduced, production efficiency is improved and production costs are reduced.
[0046] In some embodiments, the porogen includes one or more of toluene, isobutyl alcohol, polyethylene glycol, and glycerol.
[0047] Specifically, in some embodiments, toluene and isobutanol are used as porogens because they have good chemical stability and are not easy to react with monomers during the reaction. Secondly, toluene has low polarity and high volatility, and can create a larger pore space in the reaction system. Isobutanol has certain solubility and good dispersibility, which can not only make the monomers evenly distributed in the reaction system, but also adjust the polarity of the reaction system, affect the interaction between monomers, and thus control the rate of polymerization and the structure of the product.
[0048] In some embodiments, the dispersing agent includes one or more of gelatin, polyvinyl alcohol, and hydroxyethyl cellulose.
[0049] Specifically, gelatin, polyvinyl alcohol, and hydroxyethyl cellulose all contain a large number of hydrophilic groups, which can form hydrogen bonds with water molecules or perform other interactions, thereby enhancing their solubility and dispersibility in water; in addition, gelatin, polyvinyl alcohol, and hydroxyethyl cellulose also have a certain steric hindrance effect. In a dispersed system, the molecules of these substances can form an adsorption layer on the surface of the particles, which prevents the aggregation and agglomeration of substances through the steric hindrance effect, thereby maintaining the stability of the dispersed system. In some embodiments, the above-mentioned dispersant helps to evenly disperse the oil phase in the water phase, prevents the aggregation and agglomeration of the oil phase, and always maintains the uniformity and stability of the reaction system.
[0050] Preferably, the dispersant includes gelatin and polyvinyl alcohol, and the mass ratio of gelatin to polyvinyl alcohol is 1:(1-10).
[0051] Specifically, in some embodiments, the dispersant includes the above-mentioned polyvinyl alcohol and gelatin, which can further improve the dispersion characteristics of the aqueous phase, making the prepared macroporous resin more uniform in texture and more stable in performance.
[0052] In some embodiments, the initiator includes one or more of benzoyl peroxide and azobisisobutyronitrile.
[0053] Specifically, in some embodiments, benzoyl peroxide is used as an initiator to enable the monomer to undergo rapid polymerization reaction within a wider temperature range, thereby improving the reaction efficiency; and the decomposition product of azobisisobutyronitrile is relatively harmless. Using azobisisobutyronitrile as an initiator in the production process can reduce the harm of the macroporous resin preparation method to the environment.
[0054] In some embodiments, in step S3, the time for adding the oil phase dropwise into the water phase does not exceed 10 minutes.
[0055] Specifically, in some embodiments, reasonable control of the rate and time of two-phase mixing can reduce unnecessary time consumption, improve production efficiency, and reduce production costs while ensuring product quality.
[0056] The applicant further provides the following reference specific embodiments to describe the present invention. It should be noted that these embodiments are merely illustrative and do not limit the present invention in any way.
[0057] Example 1
[0058] This embodiment provides a method for preparing a biopolyphenol macroporous resin, and the specific steps are as follows:
[0059] Step S1, preparing oil phase and water phase respectively, wherein:
[0060] Prepare the oil phase: mix 66 g of magnolol, 60 g of toluene and 0.5 g of benzoyl peroxide, stir evenly to obtain an oil phase;
[0061] Prepare the aqueous phase: place 1.2 g of gelatin and 200 mL of water in a heating device, heat and stir to completely dissolve the gelatin, and obtain the aqueous phase;
[0062] Step S2, continuously stirring the water phase, introducing nitrogen into the heating device for protection, and dripping the oil phase into the water phase, completing the dripping within 10 minutes to obtain a mixture;
[0063] Step S3, heating the mixture to 90° C., and stirring at 90° C. for 6 hours to obtain a solid-liquid mixture;
[0064] Step S4, separating the solid product from the solid-liquid mixture, repeatedly washing the solid product with ethanol and water, and removing the impurities and toluene remaining in the pores of the product by Soxhlet extraction to obtain a biopolyphenol-based macroporous resin.
[0065] In this embodiment, the biopolyphenol monomer is magnolol; the porogen is toluene; the dispersant is gelatin; and the initiator is benzoyl peroxide.
[0066] The biopolyphenol-based macroporous resin prepared above was subjected to the following performance tests:
[0067] Test 1: Middle molecule toxin clearance test (bovine serum albumin clearance effect test)
[0068] Prepare phosphate buffered saline (PBS, pH=7.4) containing 0.1% bovine serum albumin (BSA), and add β2-microglobulin to the above buffer to prepare a β2-microglobulin solution with a concentration of 10 mg / L. Take 10 mL of the above-prepared β2-microglobulin solution and place it in a conical flask. Weigh 0.2 g of macroporous resin and place it in a conical flask at a temperature of The constant temperature oscillator is set at 180 The adsorption was carried out at a rate of 10 times / min for 2 hours. After the adsorption, the concentration of β2-microglobulin solution was measured by biochemical analyzer, and the adsorption rate was calculated according to the following formula:
[0069]
[0070] Where:
[0071] C r4 —β2-microglobulin adsorption rate, ;
[0072] C0─concentration of β2-microglobulin solution before adsorption, in mg / L;
[0073] C t ─Concentration of β2-microglobulin solution after 2 hours of adsorption, in mg / L.
[0074] Test 2: Middle molecule toxin clearance test (IL-6 effect test)
[0075] Prepare phosphate buffered saline (PBS, pH=7.4) containing 0.1% bovine serum albumin (BSA), and add IL-6 to the buffer to prepare an IL-6 solution with a concentration of 600 pg / mL. Take 10 mL of the prepared IL-6 solution and place it in a conical flask. Then weigh 0.5 g of macroporous resin and place it in a flask at 37 1℃ constant temperature oscillator at 180 The adsorption was carried out at a speed of 10 r / min for 2 hours. After the adsorption, the concentration of IL-6 before and after adsorption was measured by ELISA (ELISA kit: purchased from BD Company, USA), and the adsorption rate of IL-6 (%) was calculated according to the following formula:
[0076]
[0077] Where A is the adsorption rate (%);
[0078] C1 and C2 are the concentrations of IL-6 before and after adsorption (pg / mL), respectively.
[0079] Test 3: Hydrophilicity test
[0080] The macroporous resin prepared above was dried at 105°C for 4 hours to remove moisture from the macroporous resin. After drying, the resin was ground and then prepared into a sheet sample with a diameter of 13 mm and a thickness of 1 mm using an oil pressure tablet press, and then the contact angle test was performed.
[0081] Test 4: Hemolysis rate test
[0082] Take 2g of the macroporous resin prepared above in a test tube and inject 10mL of normal saline as the test tube. Put the test tube, negative tube (only inject 10mL of normal saline), and positive tube (only inject 10mL of distilled water) in a 37℃ water bath and keep warm for 30min. After the insulation is completed, add 0.2mL of diluted anticoagulated rabbit blood to the test tube, negative tube, and positive tube respectively, shake gently to mix, and place the test tube, negative tube, and positive tube in a constant temperature water bath at 37℃ again for 60min. After the insulation is completed, pour out the liquid in the tube, centrifuge it at a centrifugal force of 800N for 5min, then take the supernatant in the tube and place it in a UV spectrophotometer, measure the absorbance at 545nm, and calculate the hemolysis rate according to the following formula (the hemolysis rate should be ≤5%):
[0083]
[0084] Where: A─absorbance of the test solution;
[0085] B─ absorbance of negative control solution;
[0086] C─ Absorbance of positive control solution.
[0087] Test 5: Dynamic adsorption performance test of β2-microglobulin
[0088] To simulate the dynamic adsorption test in clinical practice, 2g of the macroporous resin prepared above was accurately weighed and placed in a chromatography column, and 80mL of bovine whole blood solution containing 10mg / L β2-microglobulin was taken for dynamic adsorption test. The adsorption time was 240min. After the adsorption, the contents of β2-microglobulin, albumin and total protein in the bovine whole blood solution were detected before and after the test.
[0089] Example 2
[0090] The difference from Example 1 is that the raw materials and heating parameters are different:
[0091] The biopolyphenol monomers include magnolol and eugenol, and the mass ratio of magnolol to eugenol is 1:2, specifically 20g magnolol and 40g eugenol; the porogen is 50g toluene; the dispersant is 1.08g hydroxyethyl cellulose; the initiator is 0.4g benzoyl peroxide;
[0092] The second heating temperature is 80°C and the insulation time is 8h.
[0093] Example 3
[0094] The difference from Example 1 is that the raw materials and heating parameters are different:
[0095] The biopolyphenol monomers include magnolol and resveratrol, and the mass ratio of magnolol to resveratrol is 1:6, specifically 10g magnolol and 60g resveratrol; the porogen is 40g isobutyl alcohol; the dispersant includes polyvinyl alcohol and gelatin, and the mass ratio of polyvinyl alcohol to gelatin is 5:1, specifically 1.0g polyvinyl alcohol and 0.2g gelatin; the initiator is 0.7g azobisisobutyronitrile;
[0096] The second heating temperature is 95°C and the insulation time is 6h.
[0097] Comparative Example 1
[0098] In this embodiment, the performance test in Example 1 was performed using a disposable hemoperfusion device KCM-150 resin (hydrophilic modified polystyrene resin).
[0099] The results of the above examples and comparative examples can be found in Table 1.
[0100] Table 1
[0101]
[0102] According to the test results in this embodiment,
[0103] The test data of Examples 1 to 3 and Comparative Example 1 are as follows: Example 1 uses magnolol as a biological polyphenol monomer, toluene as a porogen, gelatin as a dispersant, and benzoyl peroxide as an initiator. The prepared macroporous resin has a contact angle of 76.6°, a β2-microglobulin clearance rate of 96.25%, an IL-6 clearance rate of 97.28%, a hemolysis rate of 0.25%, and an albumin adsorption rate of 2.62%; the biological polyphenol monomers in Example 2 include magnolol and eugenol, toluene as a porogen, hydroxyethyl cellulose as a dispersant, and benzoyl peroxide as an initiator. The prepared macroporous resin has a contact angle of 76.6°, a β2-microglobulin clearance rate of 96.25%, an IL-6 clearance rate of 97.28%, a hemolysis rate of 0.25%, and an albumin adsorption rate of 2.62%. The contact angle of the macroporous resin is 79.8°, the clearance rate of β2-microglobulin is 94.76%, the clearance rate of IL-6 is 96.35%, the hemolysis rate is 0.42%, and the albumin adsorption rate is 1.65%; the biological polyphenol monomers in Example 3 include magnolol and resveratrol, isobutyl alcohol is a porogen, polyvinyl alcohol and gelatin are dispersants, and azobisisobutyronitrile is an initiator. The prepared macroporous resin has a contact angle of 75.2°, a clearance rate of β2-microglobulin is 95.25%, a clearance rate of IL-6 is 96.16%, a hemolysis rate is 0.08%, and an albumin adsorption rate is 0.68%. Comparative Example 1 uses a disposable blood perfusion device KCM-150 resin (hydrophilic modified polystyrene resin) as an adsorption resin, and its performance is tested. The results are as follows: the contact angle is 79.5°, the clearance rate of β2-microglobulin is 96.48%, the clearance rate of IL-6 is 98.75%, the hemolysis rate is 0.15%, and the albumin adsorption rate is 2.8%.
[0104] From the experimental data, it can be seen that Example 1 The contact angles of the macroporous resins prepared in Examples 3 are all below 80°, which is equivalent to the hydrophilicity of the blood perfusion resin in Comparative Example 1, and the hemolysis rates are all below 0.5%, and the adsorption rates of albumin are all below 5%, indicating that the adsorption materials prepared in Examples have strong selective adsorption capacity, and are both safe and effective during application, and can meet the safety requirements of blood perfusion adsorption materials. According to the β2-microglobulin clearance rate and IL-6 clearance rate, the adsorption performance of the adsorption resin for macromolecular substances can be obtained. The β2-microglobulin clearance rate and IL-6 clearance rate of the macroporous resins prepared in Examples 1 to 3 are both higher than 94% and 96%, respectively, indicating that the macroporous resins prepared in Examples 1 to 3 also have strong adsorption capacity. In summary, the embodiments of the present invention simplify the preparation process of macroporous resin and improve the safety of production by adjusting the dosage of biophenol monomer, porogen, initiator and dispersant; and also control the morphology and performance of macroporous resin so that the macroporous resin has good selective adsorption performance, and finally obtain a macroporous resin with high safety and good removal effect, so that the macroporous resin will not cause the loss of a large amount of beneficial proteins in the human body when removing harmful macromolecules in the blood.
[0105] In addition, in Example 3, the biopolyphenol monomers include magnolol and resveratrol, the dispersants include polyvinyl alcohol and gelatin, isobutanol is used as a porogen, and azobisisobutyronitrile is used as an initiator. The prepared macroporous resin has the strongest hydrophilicity, the lowest hemolysis rate, and the best selective adsorption capacity. Therefore, in actual application, the macroporous resin prepared by the method of Example 3 is safer.
[0106] In summary, the solution of the present invention has the following beneficial effects:
[0107] (I) The present invention utilizes bio-polyphenols to prepare macroporous resins. Since bio-polyphenols are extracted from biological materials, their own toxicity is relatively low, and thus the impact on humans and the environment can be reduced during the preparation stage of the macroporous resin.
[0108] (ii) The macroporous resin prepared by the present invention has hydrophilicity and blood compatibility comparable to those of existing perfusion products, and can meet the use requirements of perfusion resin without subsequent hydrophilic modification, and can be directly applied in the field of blood perfusion.
[0109] The above are only preferred embodiments of the present application and are not intended to limit the present invention. Although the present application has been described in detail with reference to the examples, those skilled in the art can still modify the technical solutions recorded in the aforementioned examples or make equivalent substitutions for some of the technical features therein. However, any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present application should be included in the protection scope of the present application.
Claims
1. A method for preparing a biopolyphenol macroporous resin, characterized in that: The following steps are involved: Step S1, preparing oil phase and water phase respectively, wherein: Prepare the oil phase: mix the biopolyphenol monomer, porogen and initiator, and stir evenly to obtain the oil phase; Preparing an aqueous phase: placing a dispersant and water in a heating device, heating to a first temperature, and stirring to completely dissolve the dispersant in the water to obtain an aqueous phase; Step S2, continuously stirring the water phase, introducing nitrogen into the heating device for protection, and dropping the oil phase into the water phase to complete the dropping to obtain a mixture; Step S3, heating the mixture to a second temperature, stirring and keeping warm for a first period of time, to obtain a solid-liquid mixture; Step S4, separating the solid product from the solid-liquid mixture, washing the solid product, and obtaining a biopolyphenol-based macroporous resin.
2. The method for preparing the biopolyphenol macroporous resin according to claim 1, characterized in that: The biopolyphenol monomers include one or more of magnolol, resveratrol and eugenol.
3. The method for preparing the biopolyphenol macroporous resin according to claim 1 or 2, characterized in that: The biopolyphenol monomers include magnolol and resveratrol, and the mass ratio of magnolol to resveratrol is 1:(1-6).
4. The method for preparing the biopolyphenol macroporous resin according to claim 1, characterized in that: The mass ratio of the biopolyphenol monomer, porogen and initiator is 1: (0.5-1.2): (0.003-0.01); The mass ratio of the dispersant to water is 1: (0.005-0.015); The volume ratio of the oil phase to the water phase is 1:(1-3).
5. The method for preparing the biopolyphenol macroporous resin according to claim 1, characterized in that: In step S3, the second temperature is 80-95° C., and the first insulation time is 4-10 hours.
6. The method for preparing the biopolyphenol macroporous resin according to claim 1, characterized in that: The dispersant includes one or more of gelatin, polyvinyl alcohol, and hydroxyethyl cellulose.
7. The method for preparing the biopolyphenol macroporous resin according to claim 1 or 6, characterized in that: The dispersant includes gelatin and polyvinyl alcohol, and the mass ratio of gelatin to polyvinyl alcohol is 1:(1-10).
8. A biopolyphenol macroporous resin prepared by the preparation method according to any one of claims 1 to 7.
9. The biopolyphenol macroporous resin according to claim 8, characterized in that: The average pore size of the biopolyphenol macroporous resin is 10 to 15 nm.
10. A use of the biopolyphenol macroporous resin prepared by the preparation method according to any one of claims 1 to 7 or the biopolyphenol macroporous resin according to claim 9, characterized in that: Used in the field of blood purification.
11. The use of the biopolyphenol macroporous resin according to claim 10, characterized in that: Used to adsorb substances with molecular weight of 10KD to 60KD.
